15-48494209-C-G
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000138.5(FBN1):c.2723G>C(p.Cys908Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C908R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000138.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
A likely pathogenic variant has been identified in the FBN1 gene. The C908S variant has not been published as apathogenic variant, nor has it been reported as a benign variant to our knowledge. C908S was not observed inapproximately 6,500 individuals of European and African American ancestry in the NHLBI Exome SequencingProject, indicating it is not a common benign variant in these populations. The C908S variant is conserved acrossspecies, and is a non-conservative amino acid substitution, which is likely to impact secondary protein structure asthese residues differ in polarity, charge, size and/or other properties. Consequently, in silico analysis predicts thisvariant is probably damaging to the protein structure/function. Multiple other missense variants at the same residue(C908G, C908R, C908Y) have been reported in the Human Gene Mutation Database in association with Marfansyndrome (Stenson et al., 2014); however, the pathogenicity of these variants has not been definitely determined dueto lack of segregation and functional data. Moreover, while the C908S variant affects a Cysteine residue, it is notlocated within a calcium-binding EGF-like domain of the FBN1 gene. Cysteine substitutions in the calcium-bindingEGF-like domains represent the majority of pathogenic missense changes associated with Marfan syndrome (Collod-Beroud et al., 2003).In summary, C908S in the FBN1 gene is interpreted as a likely pathogenic variant. -
Marfan syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at